DNAprint Genomics (DNAG)

[ann441j]

"We are currently preparing for a Pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) to discuss the preclinical studies for PT-401.

"Other therapies in our product pipeline include Ritalin(tm)-like compounds for the potential treatment of drug abuse, attention deficit hyperactivity disorder (ADHD), and depression," Dr. Gomez said. "These compounds are analogs of Ritalin, a well-known drug used for treatment of ADHD and designed specifically to take effect slowly but last longer, thus reducing the potential for cardiovascular complications, abuse and a patient's required daily dosage."

Ann